On 24 May 2026, the European Chemicals Agency (ECHA) added di-cyclohexyl phthalate (DCHP) and three other plasticizers to the Candidate List of Substances of Very High Concern (SVHC) under REACH. This regulatory update directly impacts exporters of natural ingredient formulations—especially those containing plant-based emulsifiers or microencapsulation wall materials—and triggers mandatory SCIP database notification prior to placing products on the EU market.

Regulatory Update Confirmed by ECHA

On 24 May 2026, ECHA officially included DCHP and three additional plasticizers in the SVHC candidate list. Under the revised obligation, all mixtures containing these substances—including natural-ingredient-based products such as vegetable oil-derived emulsifiers and microcapsule shell materials—must be registered in the SCIP (Substances of Concern In Products) database before being placed on the EU market. Non-compliant consignments will be denied customs clearance and excluded from key distribution channels in Germany, France, and other major EU markets.

Impact Across the Natural Ingredients Value Chain

Exporters and Direct Trading Companies

These entities face immediate shipment delays and market access barriers if SCIP submissions are incomplete or inaccurate. Customs rejection now applies at first entry points—including Rotterdam and Hamburg—making pre-shipment compliance verification essential.

Raw Material Sourcing Firms

Suppliers of botanical extracts, carrier oils, or functional excipients must now provide updated substance declarations—including presence/absence statements for DCHP and related SVHCs—to downstream formulators. Lack of documentation may interrupt procurement cycles and trigger contractual non-compliance clauses.

Formulation and Manufacturing Facilities

Manufacturers using plasticized polymers or stabilizing agents in encapsulation processes must reassess material safety data sheets (SDS), conduct batch-level SVHC screening, and integrate SCIP reporting into their release workflows—particularly for B2B ingredients supplied to EU-based blenders or finished-product brands.

Supply Chain and Regulatory Support Providers

Third-party compliance consultants, testing labs, and SCIP submission platforms are seeing increased demand for substance identification support, dossier validation, and multi-language technical documentation—especially for complex natural matrices where DCHP may originate from recycled packaging or processing aids.

Key Compliance Actions for Affected Businesses

Verify SVHC Presence Across Ingredient Matrices

Conduct targeted analytical screening—not just supplier declarations—for DCHP in emulsifiers, film-forming agents, and microcapsule coatings. Natural origin does not preclude contamination or intentional use during processing.

Integrate SCIP Submission into Product Launch Timelines

Treat SCIP registration as a prerequisite for market entry—not a post-import administrative step. Allow minimum 5–7 working days for dossier validation and system confirmation before scheduled EU shipments.

Update Technical Documentation and Supplier Agreements

Revise SDS sections 3 and 15, revise quality agreements to include SVHC disclosure obligations, and require upstream suppliers to confirm absence of all four newly listed substances—or specify concentration thresholds per REACH Article 33.

Prepare for Cross-Border Traceability Requirements

Ensure batch-level traceability systems can link SCIP notification IDs to specific production lots, especially for multi-component natural blends distributed via EU toll manufacturers or contract packagers.

Industry Perspective: Beyond Compliance, Toward Proactive Substance Governance

Analysis shows this update reflects a broader shift toward granular, product-level chemical transparency—even within traditionally low-regulation categories like natural ingredients. It is more appropriate to understand this as an acceleration of supply chain due diligence expectations, rather than an isolated listing event. What deserves closer attention is the growing time-to-readiness gap: many SMEs lack internal capacity for rapid SVHC screening and SCIP dossier generation, making third-party support increasingly strategic—not optional. From an industry perspective, the 2026 DCHP listing signals that ‘natural’ no longer implies ‘regulatory-exempt’, and proactive substance inventory management is becoming foundational to EU market access.

Strategic Implications for Market Participants

This development underscores that regulatory readiness for natural-ingredient exports is no longer defined solely by organic certification or GMO status—but by precise chemical composition accountability. Companies treating SCIP as a one-time filing exercise risk repeated customs disruptions. A sustainable approach requires embedding SVHC monitoring into R&D, procurement, and quality assurance—not just compliance departments. The long-term implication is a convergence of natural product standards with industrial chemical governance frameworks.

Source Attribution and Ongoing Monitoring

This article is based exclusively on the user-provided information: title, event date (24 May 2026), and summary description. Specific official source links were not provided in the input and should be verified continuously. Stakeholders are advised to monitor ECHA’s official SVHC updates, national helpdesks (e.g., Germany’s BAuA, France’s ANSES), and forthcoming guidance on SCIP reporting for complex mixtures—particularly those involving botanical matrices where SVHC detection thresholds and declaration responsibilities remain subject to interpretation.